Report - BiondVax Pharmaceuticals Ltd. Universal Flu Vaccinevaccination, partial TIV dose (15% or 50%). Phase II (BVX‐005): 120 participants, ♀♂, 65‐91 years old. Aug 2011 –Feb 2012.

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form